https://www.zonebourse.com/cours/action/NEUROSENSE-THERAPEUTICS-L-130483704/actualite/NeuroSense-Therapeutics-Ltd-acheve-le-dosage-du-dernier-patient-du-segment-en-double-aveugle-de-l-45300509/?utm_source=telegram&utm_medium=social&utm_campaign=share